Adicet Bio, Inc. Share Price & Technical Analysis
ACET · $8.30 (+5.20%)
Healthcare / Biotechnology
$8.30
+5.20%
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops A…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
9% return in May, -1% avg return in past 3 year May month.
2% return in 2026, -67% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -5% | -9% | -4% | 10% | 9% | – | – | – | – | – | – | – | 2% |
| 25 | -8% | 4% | -17% | -14% | 8% | -15% | 11% | 5% | 10% | -6% | -13% | -21% | -57% |
| 24 | 58% | -22% | -1% | -37% | -6% | -19% | 24% | -6% | 0% | -9% | -13% | -15% | -45% |
| 23 | 1% | -14% | -27% | 2% | -6% | -52% | 10% | -25% | -31% | -4% | -11% | 59% | -98% |
| 22 | -29% | 2% | 55% | -27% | -20% | 23% | 16% | -15% | 2% | 13% | 9% | -51% | -23% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Uptrend
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$73.48M
P/E ratio
—
52W high
$17.44
52W low
$6.01
Volume
92,027
Beta
1.51
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Adicet Bio, Inc. share price today?
- Adicet Bio, Inc. (ACET) last traded around $8.30 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ACET have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ACET. Download the app for real-time alerts.
- How can I analyze Adicet Bio, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.